Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages


This content is available also in other languages

May 31, 2007 | Customer News

Japan Tobacco’s drug discovery team turns to Tecan and REMP for automated sample management

  Pharmaceutical research scientists at Japan Tobacco, Inc (JT) have two Genesis RWS™ workstations from Tecan, one equipped with a REMP Tube Punching Module™ (TPM), for discovery of ‘seed’ compounds with specific or unique pharmaceutical effects on potential target molecules such as enzymes and receptors. Twenty or thirty seed compounds are eventually selected from hundreds of thousands of compounds that are routinely investigated for potential therapeutic use in areas such as diabetes, immunology, viral diseases and bone disorders.

Dr Akira Ohta, Senior Researcher at JT, explained: “The Genesis/TPM system is extremely simple to use and one person can easily control the process. REMP’s 384 Tube Technology™ was straightforward to integrate into our workflow and the system helps to minimize the absorption of moisture during cherry picking, improving the quality of the compound solution and virtually eliminating loss of compound activity during the evaluation steps. It can pick as many as 700 tubes in an hour and the automated barcoding system removes the inevitable risk of human error that would be associated with handling this kind of throughput manually.”

About Tecan

Tecan (www.tecan.com) is a leading global supplier of solutions for the biopharma, forensic and diagnostic industries. The company is a leader in the development, production and distribution of advanced automation and detection solutions for the world’s leading life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of large-scale automated laboratory storage and logistics systems. Founded in Switzerland in 1980, the company has over 1100 employees, owns production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2006, Tecan achieved sales of CHF 405.9 million (USD 324.7 million; EUR 258.6 million). Shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 12100191).

For further information please contact:

Tecan Switzerland AG
Seestrasse 103
CH-8708 Männedorf

T +41 44 922 81 11
F +41 44 922 81 12